Research for people
The Laurenz Herting Foundation is an independent, non-profit foundation. It promotes medical research into the treatment of cancer, MS and COPD. Every donation supports projects that break new ground in therapy. Donate for a future with better health and quality of life.
Donate now
and save lives
Research for people
The Laurenz Herting Foundation is an independent, non-profit foundation. It promotes medical research into the treatment of cancer, MS and COPD.
Donate now
and save lives
Welcome to the Laurenz Herting Foundation

Together for better health: New approaches in research for breast and prostate cancer, MS and COPD

In a world where cancer, multiple sclerosis (MS) and chronic obstructive pulmonary disease (COPD) continue to pose one of the greatest challenges to healthcare, the Laurenz Herting Foundation is actively committed to advancing research and improving the lives of those affected. With a clear mission and a large number of planned projects, we want to promote innovative approaches and assume social responsibility.

We support projects that aim to explore new therapeutic avenues, promote education and awareness of cancer, MS and COPD and their prevention.

Research priorities of the Laurenz Herting Foundation

Fighting diseases together

The Laurenz Herting Foundation is dedicated to important areas of research. These not only affect our society, but also have a direct impact on the lives of many people.

Our current focus areas include

  • Breast cancer research
  • Investigations into prostate cancer
  • Studies on multiple sclerosis (MS) and
  • Research into COPD (Chronic Obstructive Pulmonary Disease).

Current projects of the Laurenz Herting Foundation

Donate for more resilience

Study for digital MS training

Multiple sclerosis poses major challenges for those affected. The innovative online resilience training "READY for MS" promises hope for improvement. [..]
New perspectives for prostate cancer

Early detection with precision

The research project is dedicated to identifying risk factors for prostate cancer in men with a family history of tumors. Using state-of-the-art MRI diagnostics, high-risk patients are to be detected at an early stage and given optimal treatment.